S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.12%) $83.24
Gas
(0.46%) $1.760
Gold
(-0.29%) $2 406.70
Silver
(-0.34%) $28.75
Platinum
(-0.05%) $943.30
USD/EUR
(-0.15%) $0.938
USD/NOK
(-0.15%) $11.03
USD/GBP
(0.53%) $0.808
USD/RUB
(-0.74%) $93.20

Realtime updates for Glenmark Life Sciences [GLS.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated19 Apr 2024 @ 05:59

0.33% INR 802.65

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 05:59):

Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India...

Stats
Today's Volume 76 777.00
Average Volume 157 325
Market Cap 98.35B
EPS INR9.69 ( 2023-10-20 )
Last Dividend INR21.00 ( 2023-03-24 )
Next Dividend INR0 ( N/A )
P/E 18.94
ATR14 INR1.525 (0.19%)

Volume Correlation

Long: 0.14 (neutral)
Short: -0.73 (moderate negative)
Signal:(52.333) Neutral

Glenmark Life Sciences Correlation

10 Most Positive Correlations
APCOTEXIND.NS0.907
AMIORG.NS0.849
RAMKY.NS0.83
RAMRAT.NS0.814
MAXVIL.NS0.811
GMRINFRA.NS0.801
10 Most Negative Correlations
LTGILTBEES.NS-0.87

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Glenmark Life Sciences Correlation - Currency/Commodity

The country flag -0.42
( neutral )
The country flag -0.37
( neutral )
The country flag 0.55
( weak )
The country flag 0.27
( neutral )
The country flag 0.46
( neutral )
The country flag 0.42
( neutral )

Glenmark Life Sciences Financials

Annual 2022
Revenue: INR21.61B
Gross Profit: INR11.47B (53.08 %)
EPS: INR38.11
Q3 2023
Revenue: INR5.73B
Gross Profit: INR3.31B (57.72 %)
EPS: INR9.69
Q2 2023
Revenue: INR5.95B
Gross Profit: INR3.22B (54.13 %)
EPS: INR9.69
Q1 2023
Revenue: INR5.78B
Gross Profit: INR3.30B (57.12 %)
EPS: INR11.05

Financial Reports:

No articles found.

Glenmark Life Sciences Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR10.50
(N/A)
INR0
(N/A)
INR21.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Glenmark Life Sciences Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.13 - low (37.37%) | Divividend Growth Potential Score: 5.65 - Stable (13.02%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR10.50 2021-11-22
Last Dividend INR21.00 2023-03-24
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out INR42.00 --
Avg. Dividend % Per Year 1.99% --
Score 2.79 --
Div. Sustainability Score 4.13
Div.Growth Potential Score 5.65
Div. Directional Score 4.89 --
Next Divdend (Est)
(2024-04-23)
INR0 Estimate 0.00 %
Dividend Stability
0.07 Very Bad
Dividend Score
2.79
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2021 INR10.50 1.40%
2022 INR10.50 1.68%
2023 INR21.00 5.03%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RUSHIL.NS Dividend Junior 2023-09-15 Annually 14 0.12%
LOTUSEYE.NS Dividend Junior 2023-09-18 Sporadic 8 0.55%
GEOJITFSL.NS Dividend Knight 2023-06-30 Annually 20 2.79%
ARVIND.NS Dividend Junior 2023-07-21 Sporadic 20 0.59%
TFCILTD.NS Dividend Junior 2023-08-11 Annually 23 1.38%
ORIENTCEM.NS Dividend Junior 2023-07-25 Annually 12 1.00%
IRFC.NS Dividend Knight 2023-09-15 Annually 4 2.61%
CUB.NS Dividend Junior 2023-08-11 Annually 23 0.35%
SHIVALIK.NS Dividend Junior 2023-09-22 Annually 3 0.03%
MANYAVAR.NS Dividend Junior 2023-08-17 Annually 3 0.31%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2191.5005.618.42[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.3121.5007.6510.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM537.041.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM6.612.007.8010.00[0 - 30]
freeCashFlowPerShareTTM6.612.006.6910.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.5591.0004.014.01[0.2 - 0.8]
operatingProfitMarginTTM0.2951.0006.106.10[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.13

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM19.281.0008.150[1 - 100]
returnOnEquityTTM0.3122.508.4910.00[0.1 - 1.5]
freeCashFlowPerShareTTM6.612.007.8010.00[0 - 30]
dividendYielPercentageTTM2.751.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM6.612.007.8010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.081.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03421.000-1.6450[0.1 - 0.5]
Total Score5.65

Glenmark Life Sciences

Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin for diabetes; and Etoricoxib and Lornoxicam for pain management. It also provides Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas. In addition, the company offers contract development and manufacturing services to a range of multinational pharmaceutical and specialty pharmaceutical companies. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators